معرفی
Callum Davidson is a Research Fellow at the University of Strathclyde, affiliated with the Strathclyde Institute Of Pharmacy And Biomedical Sciences. He holds a PhD and a Master of Chemistry in Forensic and Analytical Chemistry. His research focuses on lipid biochemistry, nanoparticle technology, and drug delivery systems, with a particular emphasis on antisense oligonucleotide therapeutics and immunoglobulin E-based cancer therapies.
Key projects include the EPSRC-funded DTP 2224 project (2022–2026), investigating antisense oligonucleotide delivery mechanisms. Davidson contributes expertise in analytical chemistry techniques like hydrophilic interaction chromatography and biophysical characterization of therapeutic agents. His work aligns with UN SDG goals related to health and innovation.
Recent research highlights include studies on the stability of MOv18 IgE (an anti-cancer IgE antibody) and lipid nanoparticle formulations for RNA therapeutics. Collaborations span academic and industry partners, emphasizing translational research in pharmaceutical science.
Davidson has contributed to 17 peer-reviewed outputs, including articles, conference presentations, and datasets. His datasets explore microfluidic mixers, antibody drug stability, and lipid nanoparticle physicochemical attributes, publicly accessible via institutional repositories.
